Roles of Caveolin-1 in Angiotensin II-Induced Hypertrophy and Inward Remodeling of Cerebral Pial Arterioles

Hypertension

Volumn 67, Issue 3, 2016, Pages 623-629

  Umesalma, Shaikamjad ^a   Houwen, Frederick Keith ^a   Baumbach, Gary L ^a,b   Chan, Siu Lung ^b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF VERMONT   (United States)

Author keywords

angiotensin II; caveolin 1; hypertrophy; matrix metalloproteinase 9; mice

Indexed keywords

ANGIOTENSIN II; CAVEOLIN 1; EPIDERMAL GROWTH FACTOR RECEPTOR; GELATINASE B; PROTEIN KINASE B; SODIUM CHLORIDE; RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL PRESSURE; ARTERIOLE; ARTICLE; BLOOD VESSEL DIAMETER; BRAIN BLOOD VESSEL; CONTROLLED STUDY; FEMALE; HYPERTENSION; HYPERTROPHY; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; OSMOTIC MINIPUMP; PIAL ARTERIOLE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SYSTOLIC BLOOD PRESSURE; VASCULARIZATION; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CHEMICALLY INDUCED; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; VASCULAR REMODELING;

ANGIOTENSIN II; ANIMALS; ARTERIOLES; CAVEOLIN 1; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; HYPERTENSION; HYPERTROPHY; MICE; MICE, INBRED C57BL; RNA; VASCULAR REMODELING;

EID: 84958063867     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.115.06565     Document Type: Article

References (31)

1. Touyz RM. The role of angiotensin II in regulating vascular structural and functional changes in hypertension. Curr Hypertens Rep. 2003; 5: 155-164.
2. Sacco RL, Wolf PA, Gorelick PB. Risk factors and their management for stroke prevention: outlook for 1999 and beyond. Neurology. 1999; 53(7 suppl 4): S15-S24.
3. Baumbach GL, Sigmund CD, Faraci FM. Cerebral arteriolar structure in mice overexpressing human renin and angiotensinogen. Hypertension. 2003; 41: 50-55.
4. Chan SL, Umesalma S, Baumbach GL. Epidermal growth factor receptor is critical for angiotensin II-mediated hypertrophy in cerebral arterioles. Hypertension. 2015; 65: 806-812. doi: 10.1161/HYPERTENSIONAHA.114.04794.
5. Krajewska WM, Masłowska I. Caveolins: structure and function in signal transduction. Cell Mol Biol Lett. 2004; 9: 195-220.
6. Ushio-Fukai M, Alexander RW. Caveolin-dependent angiotensin II type 1 receptor signaling in vascular smooth muscle. Hypertension. 2006; 48: 797-803. doi: 10.1161/01.HYP.0000242907.70697.5d.
7. Chidlow JH Jr, Sessa WC. Caveolae, caveolins, and cavins: complex control of cellular signalling and inflammation. Cardiovasc Res. 2010; 86: 219-225. doi: 10.1093/cvr/cvq075.
8. Ishizaka N, Griendling KK, Lassegue B, Alexander RW. Angiotensin II type 1 receptor: relationship with caveolae and caveolin after initial agonist stimulation. Hypertension. 1998; 32: 459-466.
9. Ushio-Fukai M, Alexander RW, Akers M, Yin Q, Fujio Y, Walsh K, Griendling KK. Reactive oxygen species mediate the activation of Akt/protein kinase B by angiotensin II in vascular smooth muscle cells. J Biol Chem. 1999; 274: 22699-22704.
10. Eguchi S, Iwasaki H, Ueno H, Frank GD, Motley ED, Eguchi K, Marumo F, Hirata Y, Inagami T. Intracellular signaling of angiotensin II-induced p70 S6 kinase phosphorylation at Ser(411) in vascular smooth muscle cells. Possible requirement of epidermal growth factor receptor, Ras, extracellular signal-regulated kinase, and Akt. J Biol Chem. 1999; 274: 36843-36851.
11. Adebiyi A, Zhao G, Cheranov SY, Ahmed A, Jaggar JH. Caveolin-1 abolishment attenuates the myogenic response in murine cerebral arteries. Am J Physiol Heart Circ Physiol. 2007; 292: H1584-H1592. doi: 10.1152/ajpheart.00584.2006.
12. Baumbach GL, Heistad DD. Remodeling of cerebral arterioles in chronic hypertension. Hypertension. 1989; 13(6 pt 2): 968-972.
13. Chan SL, Baumbach GL. Deficiency of Nox2 prevents angiotensin II-induced inward remodeling in cerebral arterioles. Front Physiol. 2013; 4: 133. doi: 10.3389/fphys.2013.00133.
14. Raffetto JD, Khalil RA. Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease. Biochem Pharmacol. 2008; 75: 346-359. doi: 10.1016/j.bcp.2007.07.004.
15. Woessner JF Jr. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J. 1991; 5: 2145-2154.
16. Martinez-Lemus LA, Zhao G, Galinanes EL, Boone M. Inward remodeling of resistance arteries requires reactive oxygen species-dependent activation of matrix metalloproteinases. Am J Physiol Heart Circ Physiol. 2011; 300: H2005-H2015. doi: 10.1152/ajpheart.01066.2010.
17. Fang H, Chen W, Gao Y, Shen Y, Luo M. Molecular mechanisms associated with angiotensin-converting enzyme-inhibitory peptide activity on vascular extracellular matrix remodeling. Cardiology. 2014; 127: 247-255. doi: 10.1159/000356951.
18. Liu G, Hitomi H, Hosomi N, Shibayama Y, Nakano D, Kiyomoto H, Ma H, Yamaji Y, Kohno M, Ichihara A, Itoh H, Nishiyama A. Prorenin induces vascular smooth muscle cell proliferation and hypertrophy via epidermal growth factor receptor-mediated extracellular signal-regulated kinase and Akt activation pathway. J Hypertens. 2011; 29: 696-705. doi: 10.1097/HJH.0b013e328343c62b.
19. Friese RS, Rao F, Khandrika S, Thomas B, Ziegler MG, Schmid-Schonbein GW, O'Connor DT. Matrix metalloproteinases: discrete elevations in essential hypertension and hypertensive end-stage renal disease. Clin Exp Hypertens. 2009; 31: 521-533. doi: 10.3109/10641960802668730.
20. Tran ED, DeLano FA, Schmid-Schonbein GW. Enhanced matrix metalloproteinase activity in the spontaneously hypertensive rat: VEGFR-2 cleavage, endothelial apoptosis, and capillary rarefaction. J Vasc Res. 2010; 47: 423-431. doi: 10.1159/000281582.
21. Flamant M, Placier S, Dubroca C, Esposito B, Lopes I, Chatziantoniou C, Tedgui A, Dussaule JC, Lehoux S. Role of matrix metalloproteinases in early hypertensive vascular remodeling. Hypertension. 2007; 50: 212-218. doi: 10.1161/HYPERTENSIONAHA.107.089631.
22. Browatzki M, Larsen D, Pfeiffer CA, Gehrke SG, Schmidt J, Kranzhofer A, Katus HA, Kranzhofer R. Angiotensin II stimulates matrix metalloproteinase secretion in human vascular smooth muscle cells via nuclear factor-kappaB and activator protein 1 in a redox-sensitive manner. J Vasc Res. 2005; 42: 415-423. doi: 10.1159/000087451.
23. Bendeck MP, Zempo N, Clowes AW, Galardy RE, Reidy MA. Smooth muscle cell migration and matrix metalloproteinase expression after arterial injury in the rat. Circ Res. 1994; 75: 539-545.
24. Garrean S, Gao XP, Brovkovych V, Shimizu J, Zhao YY, Vogel SM, Malik AB. Caveolin-1 regulates NF-kappaB activation and lung inflammatory response to sepsis induced by lipopolysaccharide. J Immunol. 2006; 177: 4853-4860.
25. Sedding DG, Braun-Dullaeus RC. Caveolin-1: dual role for proliferation of vascular smooth muscle cells. Trends Cardiovasc Med. 2006; 16: 50-55. doi: 10.1016/j.tcm.2005.11.007.
26. Ushio-Fukai M, Hilenski L, Santanam N, Becker PL, Ma Y, Griendling KK, Alexander RW. Cholesterol depletion inhibits epidermal growth factor receptor transactivation by angiotensin II in vascular smooth muscle cells: role of cholesterol-rich microdomains and focal adhesions in angiotensin II signaling. J Biol Chem. 2001; 276: 48269-48275. doi: 10.1074/jbc.M105901200.
27. Hixon ML, Muro-Cacho C, Wagner MW, Obejero-Paz C, Millie E, Fujio Y, Kureishi Y, Hassold T, Walsh K, Gualberto A. Akt1/PKB upregulation leads to vascular smooth muscle cell hypertrophy and polyploidization. J Clin Invest. 2000; 106: 1011-1020. doi: 10.1172/JCI8252.
28. Sedding DG, Hermsen J, Seay U, Eickelberg O, Kummer W, Schwencke C, Strasser RH, Tillmanns H, Braun-Dullaeus RC. Caveolin-1 facilitates mechanosensitive protein kinase B (Akt) signaling in vitro and in vivo. Circ Res. 2005; 96: 635-642. doi: 10.1161/01. RES.0000160610.61306.0f.
29. Park JH, Han HJ. Caveolin-1 plays important role in EGF-induced migration and proliferation of mouse embryonic stem cells: involvement of PI3K/Akt and ERK. Am J Physiol Cell Physiol. 2009; 297: C935-C944. doi: 10.1152/ajpcell.00121.2009.
30. Chang CF, Chen SF, Lee TS, Lee HF, Chen SF, Shyue SK. Caveolin-1 deletion reduces early brain injury after experimental intracerebral hemorrhage. Am J Pathol. 2011; 178: 1749-1761. doi: 10.1016/j.ajpath.2010.12.023.
31. Frank PG, Lee H, Park DS, Tandon NN, Scherer PE, Lisanti MP. Genetic ablation of caveolin-1 confers protection against atherosclerosis. Arterioscler Thromb Vasc Biol. 2004; 24: 98-105. doi: 10.1161/01. ATV.0000101182.89118.E5.